Clinical trial
Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response…
NCT00343759 · University of Pennsylvania, Other · Withdrawn
Key facts
| NCT number | NCT00343759 |
|---|---|
| Title | Presurgical Therapy With Lapatinib to Explore Molecular Determinants of Response to EGFR/erbB2 Targeted Therapy |
| Lead sponsor | University of Pennsylvania, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Lapatinib |
| Enrollment | 0 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Jun 23, 2006 |
| Last update posted | Dec 11, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: